Groesbeck Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CDW
CDW
|
+$279K |
| 2 |
Genpact
G
|
+$253K |
| 3 |
Intercontinental Exchange
ICE
|
+$218K |
| 4 |
CVS Health
CVS
|
+$216K |
| 5 |
Kroger
KR
|
+$190K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.5M |
| 2 |
Oneok
OKE
|
+$1.92M |
| 3 |
Digital Realty Trust
DLR
|
+$1.85M |
| 4 |
CVR Energy
CVI
|
+$1.21M |
| 5 |
MPLX
MPLX
|
+$949K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.21% |
| 2 | Healthcare | 17.4% |
| 3 | Consumer Discretionary | 12.93% |
| 4 | Financials | 11.99% |
| 5 | Industrials | 11.86% |
Similar funds
Groesbeck Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Groesbeck Investment Management held 98 positions worth $72.2M, down 23% from $94M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Groesbeck Investment Management withdrew a net $20.6M in Q2 2024, closing 27 positions and reducing 30 holdings. Its most notable exit was Oneok, an estimated $1.92M position sold in full.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Groesbeck Investment Management opened a new position in Genpact worth $252K.
- Groesbeck Investment Management's largest Q2 2024 buy was Genpact: 7,831 shares worth $252K.
- Groesbeck Investment Management added most to CDW in Q2 2024, an estimated $279K increase.
- Groesbeck Investment Management's biggest Q2 2024 reduction was AbbVie, cutting an estimated $2.5M.
- Groesbeck Investment Management fully exited Oneok in Q2 2024, selling an estimated $1.92M.
- Groesbeck Investment Management's ten largest holdings make up 40% of its $72.2M portfolio in Q2 2024.
- Groesbeck Investment Management opened 3 new positions and closed 27 in Q2 2024.
- Groesbeck Investment Management's portfolio value fell 23% quarter-over-quarter to $72.2M.
Based on Groesbeck Investment Management's 13F filing for Q2 2024, filed 26 Jul 2024.